Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement

NCT: NCT06991075 · RECRUITING

NCT IDNCT06991075
StatusRECRUITING
Start Date2025-12-01
Completion2027-11
SponsorMedical University of South Carolina (OTHER)
First posted
Last updated

Brief Summary

Investigators are conducting a study to determine whether high frequency transcutaneous electrical nerve stimulation (hfTENS) is effective at reducing pain in women having an IUD inserted.

Frequently Asked Questions

What is Transcutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement?

Transcutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement is a clinical trial registered under NCT06991075. Current status: RECRUITING.

What is the status of NCT06991075?

The current status of NCT06991075 (Transcutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement) is: RECRUITING.

When did Transcutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement start?

Transcutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement started on 2025-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑